Although administration of IL-1β promotes the pathogenesis of TMEV-induced demyelinating disease, the IL-1β produced via NLRP3 proteosome activation upon viral infection is considered to be a protective mechanism against microbial infections by promoting the apoptosis of infected cells [24]. The gene discussed is NLRP3; the disease is viral infectious disease.